State of Alaska Department of Revenue Has $764,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

State of Alaska Department of Revenue lessened its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 25.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 81,908 shares of the pharmacy operator’s stock after selling 28,290 shares during the period. State of Alaska Department of Revenue’s holdings in Walgreens Boots Alliance were worth $764,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in WBA. State Street Corp grew its holdings in shares of Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after purchasing an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after buying an additional 3,329,857 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after acquiring an additional 817,762 shares during the last quarter. Thompson Siegel & Walmsley LLC increased its position in Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after acquiring an additional 934,754 shares in the last quarter. Finally, FMR LLC raised its stake in shares of Walgreens Boots Alliance by 2.5% in the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock worth $29,200,000 after acquiring an additional 80,525 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $9.70 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.47. The firm has a fifty day moving average of $10.29 and a 200-day moving average of $9.77. The firm has a market capitalization of $8.38 billion, a price-to-earnings ratio of -0.95, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.66 earnings per share. On average, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on WBA. TD Cowen lowered their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Evercore ISI lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Jefferies Financial Group cut their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Royal Bank of Canada lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Finally, Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $13.19.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.